CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 18 enrolled
Drug / intervention
Insulin Detemir mixed with RAI injection +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00564395
NCT00564395Phase 4Completed
CompareCT.gov

Role of Insulin Aspart and Detemir to Assess Glucose Excursion in Children With Type 1 Diabetes

Montefiore Medical Center·interventional·Posted Nov 28, 2007·Updated Jul 17, 2018

In Brief

A Phase 4 clinical trial evaluating Insulin Detemir mixed with RAI injection and Insulin Detemir and RAI injection for Type 1 Diabetes Mellitus. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Study of blood sugars in the children with Type 1 Diabetes Mellitus (T1DM), who are given insulin detemir and a rapid acting insulin (aspart). It is hypothesized that there is no difference in the patterns of blood sugars when detemir is given in the same syringe or in separate syringes with rapid acting insulin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 28, 2007
Enrollment StartAug 1, 2007
Primary CompletionDec 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.6 years ago

Interventions

Insulin Detemir mixed with RAI injectiondrug

Insulin Detemir mixed with RAI injection is given twice daily as subcutaneous injection

Insulin Detemir and RAI injectiondrug

Insulin detemir and RAI are given as separate injections, twice daily as subcutaneous injection